1. Home
  2. XBIT vs INFU Comparison

XBIT vs INFU Comparison

Compare XBIT & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.65

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

Logo InfuSystems Holdings Inc.

INFU

InfuSystems Holdings Inc.

HOLD

Current Price

$8.97

Market Cap

182.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
INFU
Founded
2005
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.2M
182.2M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
XBIT
INFU
Price
$2.65
$8.97
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
48.6K
118.7K
Earning Date
11-12-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
271.43
EPS
N/A
0.26
Revenue
N/A
$141,054,000.00
Revenue This Year
N/A
$8.82
Revenue Next Year
N/A
$2.90
P/E Ratio
N/A
$34.35
Revenue Growth
N/A
6.23
52 Week Low
$2.09
$4.61
52 Week High
$4.54
$11.04

Technical Indicators

Market Signals
Indicator
XBIT
INFU
Relative Strength Index (RSI) 58.82 45.37
Support Level $2.40 $8.36
Resistance Level $2.55 $8.98
Average True Range (ATR) 0.10 0.33
MACD 0.02 -0.00
Stochastic Oscillator 81.58 39.99

Price Performance

Historical Comparison
XBIT
INFU

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

Share on Social Networks: